Mesenchymal stem cells produced from human pluripotent stem cells
    1.
    发明授权
    Mesenchymal stem cells produced from human pluripotent stem cells 有权
    由人多能干细胞产生的间充质干细胞

    公开(公告)号:US09388384B2

    公开(公告)日:2016-07-12

    申请号:US13504881

    申请日:2009-10-28

    Abstract: Provided is a method for producing mesenchymal stem cells from human pluripotent stem cells, the method including: a) forming embryonic bodies from human pluripotent stem cells; b) attaching the embryonic bodies to a culture dish to induce natural differentiation of the embryonic bodies into mesenchymal stem cells; and c) performing continuous proliferative culturing of the mesenchymal stem cells while still maintaining the identity of the mesenchymal stem cells. Also, provided is a standardized method for inducing differentiation of mesenchymal stem cells, which can be broadly applied to all human pluripotent stem cells regardless of a difference in the genetic background thereof. Ultimately, the present invention can continuously mass-produces the mesenchymal stem cells necessary for regenerative medicine and cell therapy by using human pluripotent stem cells, thereby realizing practical uses of cell therapy products, and further the present invention is expected to highly contribute to treatments of incurable diseases, such as cardiovascular diseases and neurological disorders.

    Abstract translation: 提供一种从人多能干细胞产生间充质干细胞的方法,所述方法包括:a)从人多能干细胞形成胚体; b)将胚胎体附着到培养皿中以诱导胚胎体自然分化成间充质干细胞; 和c)对间充质干细胞进行连续增殖培养,同时仍保持间充质干细胞的特性。 此外,提供了诱导间充质干细胞分化的标准化方法,其可以广泛地应用于所有人多能干细胞,而与其遗传背景的差异无关。 最终,本发明可以通过使用人多能干细胞连续批量生产再生医学和细胞治疗所需的间充质干细胞,从而实现细胞治疗产品的实际应用,并且进一步预期本发明对 不治之症,如心血管疾病和神经系统疾病。

    COMPOSITION FOR SUSPENSION CULTURING OF STEM CELLS
    4.
    发明申请
    COMPOSITION FOR SUSPENSION CULTURING OF STEM CELLS 有权
    用于悬挂培养干细胞的组合物

    公开(公告)号:US20140011275A1

    公开(公告)日:2014-01-09

    申请号:US13981508

    申请日:2011-12-27

    CPC classification number: C12N5/0018 A61K31/4409 C12N5/0663 C12N2501/727

    Abstract: The present invention relates to a composition for suppressing the death of stem cells during suspension culturing, a composition for mass culturing of stem cells, and a method for suppressing cell death of stem cells during suspension culturing. The composition of the present invention can be usefully used for effective single suspension culturing of stem cells, particularly, mesenchymal stem cells, or used for mass suspension culturing under the circumstances in which cell aggregation does not occur.

    Abstract translation: 本发明涉及一种用于抑制悬浮培养期间干细胞死亡的组合物,用于干细胞的大规模培养的组合物,以及用于在悬浮培养期间抑制干细胞的细胞死亡的方法。 本发明的组合物可有效地用于干细胞,特别是间充质干细胞的有效单悬液培养,或用于在不发生细胞聚集的情况下进行大规模悬浮培养。

    Method of Inducing High Activity of Human Adipose Stem Cell and Medium Therefor
    6.
    发明申请
    Method of Inducing High Activity of Human Adipose Stem Cell and Medium Therefor 有权
    诱导人类脂肪干细胞及其介质的高活性的方法

    公开(公告)号:US20130023048A1

    公开(公告)日:2013-01-24

    申请号:US13510528

    申请日:2010-10-08

    CPC classification number: C12N5/0667 C12N2500/36 C12N2502/1305

    Abstract: The present invention relates to a method of inducing high activity of human adipose stem cells, highly active stem cells induced by the method, cell therapeutic agents including the highly active stem cells, and a medium for inducing high activity of human adipose stem cells.The method of the present invention enables a long-term culture of human adipose stem cells while maintaining high activity, production yield and differentiation potency of the stem cells through in vitro culture, even in case culture conditions are not appropriate for mature human adipocytes, security of adipocytes is not guaranteed, or adipocytes are diseased.

    Abstract translation: 本发明涉及一种诱导人类脂肪干细胞高活性的方法,由该方法诱导的高活性干细胞,包括高活性干细胞的细胞治疗剂和诱导人类脂肪干细胞高活性的培养基。 本发明的方法能够通过体外培养保持人体脂肪干细胞的长期培养,同时通过体外培养保持干细胞的高活性,产量和分化效能,即使培养条件不适合成熟的人类脂肪细胞,安全性 的脂肪细胞不能保证,或脂肪细胞患病。

    METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS, AND MESENCHYMAL STEM CELLS PRODUCED BY SAME
    8.
    发明申请
    METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS, AND MESENCHYMAL STEM CELLS PRODUCED BY SAME 有权
    用于从人源性干细胞生产间充质干细胞的方法和由其生产的骨髓干细胞

    公开(公告)号:US20120276625A1

    公开(公告)日:2012-11-01

    申请号:US13504881

    申请日:2009-10-28

    Abstract: Provided is a method for producing mesenchymal stem cells from human pluripotent stem cells, the method including: a) forming embryonic bodies from human pluripotent stem cells; b) attaching the embryonic bodies to a culture dish to induce natural differentiation of the embryonic bodies into mesenchymal stem cells; and c) performing continuous proliferative culturing of the mesenchymal stem cells while still maintaining the identity of the mesenchymal stem cells. Also, provided is a standardized method for inducing differentiation of mesenchymal stem cells, which can be broadly applied to all human pluripotent stem cells regardless of a difference in the genetic background thereof. Ultimately, the present invention can continuously mass-produces the mesenchymal stem cells necessary for regenerative medicine and cell therapy by using human pluripotent stem cells, thereby realizing practical uses of cell therapy products, and further the present invention is expected to highly contribute to treatments of incurable diseases, such as cardiovascular diseases and neurological disorders.

    Abstract translation: 提供一种从人多能干细胞产生间充质干细胞的方法,所述方法包括:a)从人多能干细胞形成胚体; b)将胚胎体附着到培养皿中以诱导胚胎体自然分化成间充质干细胞; 和c)对间充质干细胞进行连续增殖培养,同时仍保持间充质干细胞的特性。 此外,提供了诱导间充质干细胞分化的标准化方法,其可以广泛地应用于所有人多能干细胞,而与其遗传背景的差异无关。 最终,本发明可以通过使用人多能干细胞连续批量生产再生医学和细胞治疗所需的间充质干细胞,从而实现细胞治疗产品的实际应用,并且进一步预期本发明对 不治之症,如心血管疾病和神经系统疾病。

Patent Agency Ranking